Adults born outside the United States are less likely to be up to date on colorectal cancer screening than their US-born peers, an analysis of 2023 federal survey data has found.
The gap is widest among those who arrived most recently.
Of 12,016 adults surveyed, 3,826 were not up to date on any screening test recommended by the US Preventive Services Task Force — 31.8% of the sample, a weighted prevalence of 34.5% (95% CI, 33.4%–35.6%).
The cross-sectional analysis used 2023 National Health Interview Survey data and included adults aged 45 to 75 with no self-reported history of cancer — about 95.4 million US adults weighted, with a mean age of 58.8 years and 50.8% women.
It asked whether being born in or outside the country predicted falling short of screening guidelines. It also asked how long someone had lived in the United States, after the task force lowered the starting age from 50 to 45 in 2021 for adults at average risk.
After adjustment for demographic, socioeconomic and healthcare-access factors, non-US-born adults remained more likely to be nonadherent, the analysis showed. Length of residence mattered too.
The risk of nonadherence ran higher among foreign-born adults who had lived in the United States for less than 15 years. Their adjusted risk ratio was 1.25 (P = .001). Among those who had lived there 15 years or longer, it was 1.14 (P = .004).
Having no usual source of care carried the largest adjusted risk in the analysis, at 1.61.
Separate evidence on how to close such gaps comes from a retrospective, observational study. It tracked fecal immunochemical tests, or FITs, mailed to all age-eligible adult patients in a multi-state health system from January 2019 through March 2025.
Low-barrier mail-based screening has the potential to raise participation and reduce disparities, the researchers note. But it depends on people returning the test each year and acting on abnormal results.
Participation held up reasonably well across the sequence of steps, though each stage loses people:
| Screening step | Share participating |
|---|---|
| Returned an initial mailed FIT | 59% |
| Participated in a second test | 73% |
| Colonoscopy within 12 months of an abnormal result | 59% |
Rates of initial, continued and follow-up participation varied by race and ethnicity, language, payor and geography, the study reports. That points to groups that low-barrier screening alone is not reaching.
Those shortfalls track real differences in cancer risk. A commentary in CA: A Cancer Journal for Clinicians notes that only 56% of Hispanic adults aged 45 and older are up to date with colorectal screening, versus 67% of White adults.
In Puerto Rico, rates of early-onset colorectal cancer are rising 3.8% per year — higher than in other US Hispanic populations. The territory has 37% of residents living in poverty and a health system strained by hurricanes absorbing the pressure.
The commentary also flags a structural blind spot: cancer registries cannot separate data by country of origin. Its authors call that the most important limitation of the report they accompany. It matters for screening too, since country of origin, nativity and years in the United States shape cancer risk in ways a single “Hispanic” category cannot show.
The NHIS analysis points the same direction from the other end: the screening deficit is largest for the newest arrivals, the very group least likely to have a usual source of care. Since the task force dropped the starting age to 45 in 2021, screening rates have remained low among the newly eligible, the report notes — and the 2023 data suggest foreign-born adults carry a disproportionate share of that lag.
Worth a look
- France Raises Bird Flu Risk to High Across Mainland Territory
- Germany Revises S3 Guideline on Gestational Diabetes Diagnosis, Treatment
- UK Liver Disease Cases Surge Fivefold: New Screening Guidelines Issued for Millions at Risk (world-today-journal.com)
- ATM rs189037 Linked to 2.19x Lung Cancer Risk in Bangladeshi Men (archyworldys.com)